Received Oct 8, 2025
| Type | Name | Manufacturer | Dose | Lot | Route / Site |
|---|---|---|---|---|---|
| COVID19 | COVID19 (COVID19 (PFIZER-BIONTECH)) | PFIZER\BIONTECH | 1 | — | — |
psoriasis; scratches in one arm and leg; itches; This is a spontaneous report received from a Consumer or other non HCP from medical information team. A 72-year-old male patient received BNT162b2 omicron (kp.2) (COMIRNATY (2024-2025 FORMULA)), in Sep2024 as dose 1, single (Batch/Lot number: unknown) for covid-19 immunisation. The patient's relevant medical history and concomitant medications were not reported. Vaccination history included: Comirnaty (Primary Immunization series complete), for COVID-19 immunization. The following information was reported: PRURITUS (non-serious) with onset 2024, outcome "unknown", described as "itches"; PSORIASIS (non-serious) with onset 2024, outcome "unknown"; SCRATCH (non-serious) with onset 2024, outcome "unknown", described as "scratches in one arm and leg". Additional information: Reporter explained the Comirnaty vaccine one year ago, in Sep2024. He was now 73 years old and wanted to know if he should get the new vaccine or the last dose still provides protection against COVID infection. He explained that he had received a lot of Pfizer COVID vaccines. After 3 to 4 weeks from the last dose from Sep2024, he experienced psoriasis, itches and scratches in one arm and leg, although he said it wasn't too much. He wanted to know if he was still recommended to get the new vaccine. The information on the batch/lot number for BNT162b2 omicron (kp.2) will be requested and submitted if and when received.